title: Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response.
abstract: OBJECTIVE
  The uveal compartment of the eye contains extensive networks of resident macrophages and dendritic cells. These cells are now recognised to have a role in many ocular pathologies. The aim of this study was to isolate, characterise, and compare the function of ciliary body/choroid dendritic cells and macrophages from the normal eye.
  
  
  METHODS
  Explants of rat and human ciliary body/choroid were cultured in vitro for various periods of time and cells harvested either from the supernatant fluid or from enzyme digested and washed explants. The cells were then phenotyped by microscopy and flow cytometry, examined by video time lapse photomicroscopy, and analysed functionally in a series of immunoassays.
  
  
  RESULTS
  Two main types of dendritic cell were identified: large veil-like MHC class II(mid) motile but relatively non-translocatory cells and small MHC class II(hi) motile and rapidly translocating cells. Tissue macrophages mainly remained associated with the explants in culture but gradually lost their resident tissue marker (ED2) and detached from the explants as clusters of low density, large, CR3 (ED7)(+) cells, some of which underwent apoptosis. Video time lapse studies showed dendritic cells constantly interacting with large single cells and cell clusters by traversing the interstices of the cell clusters. In functional studies, freshly isolated dendritic cells were poor presenters of antigen and required activation by short term culture for acquisition of antigen presenting function. In contrast, dendritic cell depleted choroidal cell preparations containing macrophages and other cells failed to present antigen even after short term culture but augmented the antigen presenting function of dendritic cells when tested in co-culture.
  
  
  CONCLUSIONS
  At least two types of dendritic cells are present in the normal ciliary body/choroid layer of the eye. It is likely that these cells have different functions based on their motility and potential to migrate to secondary lymphoid tissue either during normal physiological homeostatic processes or during an inflammatory response. The behaviour of resident tissue myeloid cells may decide the outcome of the organism's response to stress, foreign antigen, and ageing processes such as age related macular degeneration.
authors.affiliation: Department of Ophthalmology, University of Aberdeen, Foresterhill, Aberdeen AB9 2ZD, UK. j.forrester@abdn.ac.uk
authors.forename: J V
authors.initials: JV
authors.lastname: Forrester
authors.forename: L
authors.initials: L
authors.lastname: Lumsden
authors.forename: L
authors.initials: L
authors.lastname: Duncan
authors.forename: A D
authors.initials: AD
authors.lastname: Dick
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D017209:Apoptosis; D018929:Cell Culture Techniques; D002829:Choroid / Q000276:immunology*; D002924:Ciliary Body / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D007959:Lymphocyte Culture Test, Mixed; D008264:Macrophages / Q000276:immunology*; D008858:Microscopy, Phase-Contrast; D018715:Microscopy, Video; D051381:Rats; D011917:Rats, Inbred Lew
references.citation: J Immunol. 1996 Sep 15;157(6):2262-71
references.pmid: 8805623
references.citation: Br J Ophthalmol. 1999 May;83(5):598-604
references.pmid: 10216062
references.citation: Annu Rev Immunol. 1991;9:271-96
references.pmid: 1910679
references.citation: Br J Ophthalmol. 1995 Sep;79(9):834-40
references.pmid: 7488603
references.citation: Curr Opin Immunol. 1997 Feb;9(1):10-6
references.pmid: 9039784
references.citation: Br J Ophthalmol. 2001 Jun;85(6):739-44
references.pmid: 11371497
references.citation: Immunology. 1990 Jan;69(1):127-33
references.pmid: 2138123
references.citation: Exp Eye Res. 1994 Sep;59(3):297-304
references.pmid: 7821374
references.citation: Curr Eye Res. 1988 Dec;7(12):1231-41
references.pmid: 3229134
references.citation: Clin Exp Immunol. 1999 Feb;115(2):288-93
references.pmid: 9933455
references.citation: J Exp Med. 1993 Feb 1;177(2):397-407
references.pmid: 8426110
references.citation: Immunology. 1996 Feb;87(2):250-8
references.pmid: 8698387
references.citation: Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):351-8
references.pmid: 11773639
references.citation: Histochem J. 1996 Feb;28(2):83-97
references.pmid: 8737290
references.citation: Annu Rev Immunol. 2003;21:685-711
references.pmid: 12615891
references.citation: Eur Respir J. 1994 Dec;7(12):2124-30
references.pmid: 7713193
references.citation: J Exp Med. 1993 Jun 1;177(6):1773-7
references.pmid: 8496690
references.citation: Nat Med. 2003 Nov;9(11):1390-7
references.pmid: 14566334
references.citation: Invest Ophthalmol Vis Sci. 1994 Jan;35(1):64-77
references.pmid: 8300365
references.citation: Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3234-50
references.pmid: 8045716
references.citation: J Immunol. 1997 Apr 1;158(7):3125-9
references.pmid: 9120265
references.citation: Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3083-93
references.pmid: 12824255
references.citation: Invest Ophthalmol Vis Sci. 2003 May;44(5):2004-9
references.pmid: 12714636
references.citation: Immunology. 2000 Nov;101(3):426-33
references.pmid: 11106948
references.citation: Biotechniques. 1991 Oct;11(4):520-5
references.pmid: 1793587
references.citation: Ocul Immunol Inflamm. 2000 Sep;8(3):177-87
references.pmid: 11120579
references.citation: Invest Ophthalmol Vis Sci. 1996 Sep;37(10):1940-50
references.pmid: 8814133
references.citation: J Exp Med. 1996 Aug 1;184(2):741-6
references.pmid: 8760828
references.citation: Immunology. 1990 Nov;71(3):390-6
references.pmid: 1980120
references.citation: J Leukoc Biol. 1999 Aug;66(2):205-8
references.pmid: 10449155
references.citation: Br J Ophthalmol. 1997 May;81(5):396-401
references.pmid: 9227206
references.citation: J Neuroimmunol. 1996 Aug;68(1-2):67-76
references.pmid: 8784262
references.citation: J Immunol. 1997 Nov 15;159(10):5132-42
references.pmid: 9366443
references.citation: Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2264-71
references.pmid: 12091426
references.citation: Immunity. 2003 Jul;19(1):47-57
references.pmid: 12871638
references.citation: Methods Enzymol. 1988;162:17-38
references.pmid: 3067050
references.citation: Exp Eye Res. 1987 Nov;45(5):731-45
references.pmid: 3428396
references.citation: Nat Med. 2003 Nov;9(11):1350-1
references.pmid: 14595424
references.citation: Invest Ophthalmol Vis Sci. 2003 Feb;44(2):581-9
references.pmid: 12556386
references.citation: J Immunol. 2004 Jun 1;172(11):6701-8
references.pmid: 15153486
references.citation: J Exp Med. 1998 Mar 2;187(5):733-41
references.pmid: 9480983